RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment

An International Registry in Essential Hypertension

To support physicians in their active management of hypertensive patients. By targeting specific systolic and diastolic blood pressure (BP) figures physicians will closely monitor the BP values and as such will have an individualized control of the treatment in each patient.

The following information on clinical trials is provided for information purposes only to allow patients and physicians to have an initial discussion about the trial. This information is not intended to be complete information about the trial, to contain all considerations that may be relevant to potential participation in the trial, or to replace the advice of a personal physician or health professional.

Main criteria are listed hereafter:

Inclusion Criteria:

• Adult hypertensive
• Either newly diagnosed and untreated
• or previously treated and uncontrolled Patients of both sexes with essential hypertension

Exclusion Criteria:

• Known secondary hypertension
• Known secondary curable hypertension (i.e. pheochromocytoma, aldosterone producing adenoma, Cushing disease). Patients with renal disease are not excluded.